GRAViceptive NEGlect Treatment in Acute Stroke Using Targeted Cranial ELECTrotherapy — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
Brazil
Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo University of São Paulo, Ribeirão Preto Medical School, Ribeirão Preto, São Paulo Age range
18 Years – 80 Years
Last updated February 2025